Cardium Therapeutics was a focus ticker of an article published over the weekend at the premier website for actionable stock market opinion and analysis, Seeking Alpha. Seeking Alpha handpicks articles from the world’s top market blogs, money managers, financial experts, and investment newsletters – publishing approximately 250 articles daily. Boasting more than 1 million members, the website has a strong readership among money managers, research analysts, investment bankers, and serious individual investors.
With the U.S. economy growing at an anemic 2 percent, there’s one industry that does not have iron poor blood. Niche markets within the larger vitamin and supplement industry are on fire, with some reaching double-digit growth. Although the overall supplements market has been affected by the sluggish economy and occasional regulation issues, it continues to outpace the economy, with hot offerings such as antioxidants and fish oil getting major boosts every time a news story or afternoon doctors’ show gives them a thumbs-up.
As usual, one of the big factors in the growth of any industry is its relation to the still massive boomer generation, an aging market of over 60 million people who are taking health more seriously than they ever did before. The nutritional supplements market will have this steady fire under it for at least another twenty years. But a growing health consciousness, fueled by increasing research and mass communication, has opened the door to every age level, and has helped nutritional supplements shoot well pass the $10 billion mark.
Cardium’s MedPodium Neo-Energy, Neo-Carb-Bloc and Neo-Chill Nutra-Apps provide premium science-based ingredients that have been characterized scientifically and shown to support an active lifestyle by enhancing energy, weight management, and relaxation. These Nutra-Apps are small pharmaceutically-sealed, tasteless, easy-use capsules that come in pocket-sized “one-and-done” servings. Unlike the other companies featured in the article, which include GNC Holdings, Schiff Nutrition International, and USANA Health Sciences, Cardium is unique in that the company not only offers a growing nutraceutical product line focused on the millennial consumer, but is also developing regenerative medicine products, making it attractive from multiple directions.
To read the entire article, visit http://seekingalpha.com/article/719941
For additional information on CXM, visit the company’s website at www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
